Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality — Stella

Home/Old Age/Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality

View on ClinicalTrials.gov

Recruiting

Back to Old Age trials

Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

China

Beijing Hospital, Beijing, Beijing Municipality

Peking University First Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Peking University First Hospital

Collaborators

Beijing Hospital

Enrollment target

~154 participants

Started

November 2023

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

65 Years – 90 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.